Trial Profile
Phase I Dose Escalation Study of the Pharmacokinetics, Safety and Tolerability of Rifapentine and the Effects of Increasing Doses of Rifapentine on Induction of Metabolizing Enzymes in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Rifapentine (Primary) ; Midazolam; Rifampicin
- Indications Seizures; Tuberculosis
- Focus Adverse reactions; Pharmacokinetics
- 10 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Mar 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
- 25 Jul 2010 New trial record